{"id":"NCT01412957","sponsor":"Amgen","briefTitle":"Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer","officialTitle":"A Phase 3, Multicenter, Randomized, Open-label Trial to Evaluate the Survival Benefit of Panitumumab and Best Supportive Care, Compared to Best Supportive Care Alone, in Subjects With Chemorefractory Wild-type KRAS Metastatic Colorectal Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2014-06","completion":"2016-11","firstPosted":"2011-08-09","resultsPosted":"2016-04-08","lastUpdate":"2017-03-15"},"enrollment":377,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Colorectal Cancer"],"interventions":[{"type":"OTHER","name":"Best Supportive Care (BSC)","otherNames":[]},{"type":"DRUG","name":"Panitumumab","otherNames":["Vectibix"]}],"arms":[{"label":"Panitumumab + BSC","type":"EXPERIMENTAL"},{"label":"BSC Alone","type":"OTHER"}],"summary":"The purpose of this study is to evaluate the benefit of panitumumab in addition to best supportive care compared to best supportive care alone in patients with chemorefractory wild-type KRAS (Kirsten rat sarcoma viral oncogene homolog) metastatic colorectal cancer.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"From randomization to the last on-study or long-term follow-up visit, as of the data cut-off date of 10 June 2014. The median follow-up time was 34.9 weeks (panitumumab plus BSC: 41.0 weeks; BSC alone: 25.5 weeks).","effectByArm":[{"arm":"Panitumumab + BSC","deltaMin":10,"sd":null},{"arm":"BSC Alone","deltaMin":7.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0096"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":6},"locations":{"siteCount":78,"countries":["Brazil","Canada","Chile","China","Croatia","Estonia","Greece","India","Latvia","Lithuania","Malaysia","Mexico","Philippines","Romania","Serbia","South Korea"]},"refs":{"pmids":["27736842"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":48,"n":189},"commonTop":["Rash","Hypomagnesaemia","Dermatitis acneiform","Pruritus","Abdominal pain"]}}